Atropine
4.1 Therapeutic indications
Atropine sulfate 1 mg/5 ml, solution for injection in pre-filled syringe is indicated in adults only.- As a pre-anaesthetic medication to prevent vagal reactions associated with tracheal intubation and surgical manipulation - To limit the muscarinic effects of neostigmine, when given postsurgically to counteract non-depolarising muscle relaxants- Treatment of hemodynamically compromising bradycardia and/ or atrioventricular block due to excessive vagal tone in emergency situation- Cardiopulmonary resuscitation: to treat symptomatic bradycardia and AV block- As antidote following overdosage or poisoning with acetylcholinesterase-inhibitors e.g. anticholinesterases, organophosphorus, carbamates and muscarinic mushrooms
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).